Contributing factors related to efficacy of the dipeptidyl peptidase-4 inhibitor sitagliptin in Japanese patients with type 2 diabetes

Takashi Nomiyama; Yuko Akehi; Hiromasa Takenoshita; Ryoko Nagaishi; Yuichi Terawaki; Hisahiro Nagasako; Tadachika Kudo; Takehiko Kodera; Kunihisa Kobayashi; Hidenori Urata; Toshihiko Yanase; CHAT

doi:10.1016/j.diabres.2011.08.016

Contributing factors related to efficacy of the dipeptidyl peptidase-4 inhibitor sitagliptin in Japanese patients with type 2 diabetes

Diabetes Res Clin Pract. 2012 Feb;95(2):e27-8. doi: 10.1016/j.diabres.2011.08.016. Epub 2011 Sep 6.

Authors

Takashi Nomiyama, Yuko Akehi, Hiromasa Takenoshita, Ryoko Nagaishi, Yuichi Terawaki, Hisahiro Nagasako, Tadachika Kudo, Takehiko Kodera, Kunihisa Kobayashi, Hidenori Urata, Toshihiko Yanase; CHAT

Collaborators

CHAT:
Ai Yamashita, Akira Motomura, Fumitada Hattori, Hiroaki Tanaka, Hiromi Takahashi, Hiroshi Sakai, Hiroyuki Kusuhara, Hisashi Furukawa, Hisashi Kanaya, Isao Kato, Jin Miyawaki, Junko Meren, Kazuhiko Kitajima, Keisuke Egashira, Kenichi Ono, Kenji Ashida, Koichi Arase, Koji Odera, Kotaro Kan, Kunitaka Murase, Masatsugu Ohga, Morioki Ishibashi, Naoshi Furukawa, Riku Nomiyama, Ryoko Yoshida, Shigeki Hatama, Tetsuhiro Futata, Tomoko Hyodo, Toshihiko Umei, Yasuyoshi Kitaguchi, Yoshihiro Hatta, Yoko Takeda, Akihiko Onishi, Hideaki Tojou, Hidehiro Ishii, Hideki Nogita, Hironari Shigematsu, Hiroshi Kutsukake, Hiroshi Ninomiya, Hiroyasu Kusaba, Hisao Ito, Houhi Beppu, Junichi Chihara, Junji Yanagi, Kazuaki Fujisawa, Kazuo Nakamura, Kei Miyoshi, Keiichi Iwasaki, Keiichi Midorikawa, Ken Kitajima, Ken Mori, Kenichi Tomita, Kenkichi Majima, Kenzo Iino, Kenzo Matsumoto, Kimishige Imoto, Kiyoto Shinkai, Kou Aso, Kouji Kondo, Kunihide Ishii, Manabu Sasaguri, Masahiko Mouri, Masahiro Suenaga, Masanori Shimizu, Masayoshi Yoshida, Minoru Kodera, Norimune Shinozaki, Ryutarou Aramaki, Satoe Nokamura, Shigeki Harada, Shigeo Ashizawa, Shigeyoshi Gondo, Shinichi Ando, Shodai Furuyama, Shouichiro Mori, Shunichi Oda, Shunichiro Sumi, Tadasu Matsuzaki, Takafumi Junnouchi, Takahito Doi, Takashi Sakata, Takashi Sugimura, Takatoshi Otonari, Takeshi Yagyu, Tatsuro Imashima, Teiichi Miyauchi, Tetsuji Matsuyoshi, Tomofumi Yamamoto, Tomoyuki Akashi, Toshiaki Kadokami, Toshiharu Miake, Toshihiro Yokoyama, Wakako Fujii, Yasuo Tomita, Yoshiaki Utsunomiya, Yoshihiro Kato, Yoshihiro Tsuchiya, Yoshio Yamanouchi, Yoshiyasu Yamatsu, Yoichi Tanabe, Yoichi Tsuruta, Yosuke Takamiya, Yuhei Shiga, Yuichiro Nakamura, Yuzou Yasunaga

PMID: 21899912
DOI: 10.1016/j.diabres.2011.08.016

No abstract available

Publication types

Clinical Trial
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Asia / epidemiology
Asian People* / statistics & numerical data
Biomarkers / blood
Body Mass Index
Diabetes Mellitus, Type 2 / blood
Diabetes Mellitus, Type 2 / drug therapy*
Diabetes Mellitus, Type 2 / physiopathology
Diabetic Nephropathies / blood
Diabetic Nephropathies / drug therapy*
Diabetic Nephropathies / physiopathology
Dipeptidyl-Peptidase IV Inhibitors / therapeutic use*
Female
Glycated Hemoglobin / metabolism*
Humans
Male
Middle Aged
Pyrazines / therapeutic use*
Sitagliptin Phosphate
Treatment Outcome
Triazoles / therapeutic use*

Substances

Biomarkers
Dipeptidyl-Peptidase IV Inhibitors
Glycated Hemoglobin A
Pyrazines
Triazoles
Sitagliptin Phosphate